MedTrace Logo

Decentralization of Hepatitis B Care in Sub-Saharan Africa: a Pilot Program in Ethiopia

NCT06586983 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 4500

Last updated 2024-09-19

No results posted yet for this study

Summary

The goal of this observational study is to study models of care for decentralized hepatitis B treatment in Ethiopia.

Three different models of decentralized HBV care (standard model, simplified model, test-and-treat model) will be implemented at primary hospitals or health clinics in Ethiopia. Treatment will be given for free to patients who meet the treatment criteria. We will compare clinical outcome, laboratory outcomes and programmatic outcome measures between the 3 models.

Conditions

Interventions

DRUG

Tenofovir Disoproxil Fumarate

300 mg po OD

Sponsors & Collaborators

  • Norges ForskningsrÃ¥d, Stenberggata 26, pb. 2700, N-0131 Oslo, Norway

    collaborator UNKNOWN

  • Addis Ababa University

    collaborator OTHER

  • Sykehuset i Vestfold HF

    collaborator OTHER

  • St. Paul's Hospital Millennium Medical College, Ethiopia

    collaborator OTHER

  • Oslo University Hospital

    lead OTHER

Principal Investigators

  • Asgeir Johannessen, MD PhD · The Hospital of Vestfold

  • Nega Berhe, MD PhD · Addis Ababa University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-04
Primary Completion
2028-09-05
Completion
2028-09-05

Countries

  • Ethiopia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06586983 on ClinicalTrials.gov